IPO Databook: Sunshine Biopharma (SBFM US) - Oct 2026

96 Views04 Oct 2026 10:07

SUMMARY

Sunshine Biopharma Inc. is a pharmaceutical company researching life-saving medicines in oncology and antivirals, marketing 60 generic prescription drugs, and selling OTC supplements through its Canadian subsidiaries.
The company markets 60 generic prescription drugs in Canada and is developing K1.1 mRNA for liver cancer and SBFM-PL4 for SARS Coronavirus infections.
The company reported $13,748,301 in cash as of June 30, 2026, with an accumulated deficit of $(77,823,043) and Nasdaq compliance concerns.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream